Clinical use of tumor markers in oncology

EL Jacobs, CM Haskell - Current problems in cancer, 1991 - Elsevier
The perfect tumor marker would be one that was produced solely by a tumor and secreted in
measurable amounts into body fluids, it should be present only in the presence of cancer, it …

[引用][C] Practice guidelines and recommendations for use of tumor markers in the clinic

M Fleisher, AM Dnistrian… - Tumor markers …, 2002 - AACC Washington, DC

The use of serologic tumor markers in gastrointestinal malignancies

MR Posner, RJ Mayer - Hematology/oncology clinics of North America, 1994 - Elsevier
Clinicians have desired simple tests that could be applied to readily diagnose
gastrointestinal cancers at an early stage and to subsequently monitor the treatment of these …

Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines

MJ Duffy, A van Dalen, C Haglund, L Hansson… - European journal of …, 2003 - Elsevier
In recent years, numerous serum and cell/tissue-based markers have been described for
colorectal cancer (CRC). The aim of this article was to provide guidelines for the routine …

[HTML][HTML] Carcinoembryonic antigen, carbohydrate antigen 19-9, cancer antigen 125, prostate-specific antigen and other cancer markers: a primer on commonly used …

S Desai, AK Guddati - World Journal of Oncology, 2023 - ncbi.nlm.nih.gov
Cancer markers are molecules produced by cancer cells which may serve to identify the
presence of cancer. Cancer markers can be differentiated as serum-based, radiology-based …

Role of tumor markers in patients with solid cancers: a critical review

MJ Duffy - European journal of internal medicine, 2007 - Elsevier
The measurement of tumor markers is currently one of the most rapidly growing areas in
laboratory medicine. Lack of sensitivity and specificity preclude the use of most existing …

[HTML][HTML] Serum tumor markers

GL Perkins, ED Slater, GK Sanders… - American family physician, 2003 - aafp.org
Monoclonal antibodies are used to detect serum antigens associated with specific
malignancies. These tumor markers are most useful for monitoring response to therapy and …

Validation of new cancer biomarkers: a position statement from the European group on tumor markers

MJ Duffy, CM Sturgeon, G Söletormos, V Barak… - Clinical …, 2015 - academic.oup.com
BACKGROUND Biomarkers are playing increasingly important roles in the detection and
management of patients with cancer. Despite an enormous number of publications on …

Tumor markers

JYH Chan, Z Wang - Lau WY. Hepatocelluar carcinoma …, 2008 - books.google.com
Chronic hepatitis leading to liver cirrhosis is a major risk factor for the development of
hepatocellular carcinoma (HCC). Patients with severe chronic hepatitis and cirrhosis should …

Estimating the probability of cancer with several tumor markers in patients with colorectal disease

M Carpelan-Holmström, J Louhimo, UH Stenman… - Oncology, 2004 - karger.com
Objective: The purpose of this study was to evaluate and compare serum tumor markers,
carcinoembryonic antigen (CEA), CA 19-9, CA 242, CA 72-4 and hCGβ, and their value in …